Pilot Study Using a Wireless Motility Capsule
Measurement of Whole Gut Transit Time After a Dietary Fiber Treatment Using a Wireless Motility Capsule
1 other identifier
interventional
10
1 country
1
Brief Summary
Research suggests dietary fiber may decrease transit time through the gastrointestinal tract. Research studies traditionally use radio-opaque markers to determine gastric emptying, colonic transit, and whole gut transit time. The SmartPill is a single use pill that can be used to determine gastric emptying, colonic transit, and whole gut transit time without requiring X-rays or fecal collections. Previous studies have found radio-opaque markers and the SmartPill detect the similar transit times. The purpose of this pilot study is to determine if the SmartPill can detect a change in transit time using a significant dose of dietary fiber.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2010
CompletedFirst Posted
Study publicly available on registry
April 13, 2010
CompletedResults Posted
Study results publicly available
October 27, 2014
CompletedNovember 4, 2014
October 1, 2014
8 months
March 24, 2010
February 7, 2013
October 27, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Whole Gut Transit Time
The time required for the SmartPill to travel through the entire gastrointestinal tract and be present in the feces.
5 days
Secondary Outcomes (2)
Gastrointestinal Tolerance
Day 4
Food Intake Diary
Day 1
Study Arms (1)
Low fiber and High Fiber
EXPERIMENTALSubjects consume a low fiber cereal and swallow the SmartPill device that measures gastrointestinal transit time Subjects consume a high fiber cereal along with swallowing the SmartPill device that measures gastrointestinal transit time
Interventions
Eligibility Criteria
You may qualify if:
- Healthy men and women
- Age 18 - 65
- Non-smoking
- Not taking medication
- Non-dieting
- BMI 18-30
- English literacy
- Ability to swallow the SmartPill
You may not qualify if:
- Do not regularly consume breakfast
- Food allergies to ingredients fond in study products
- Dislike of hot cereal
- BMI \<18 or \>30
- Are not weight stable
- Diagnosed with diabetes, cardiovascular, renal, or hepatic disease
- Cancer in previous 5 years (except basal cell carinoma of the skin)
- Any gastrointestinal disease or condition
- Any gastrointestinal surgeries that alter motility
- Recent antibiotic usage (\< 6 months)
- recent or concurrent participation in an intervention research study
- History of drug or alcohol abuse in prior 6 months
- Use of laxatives, anti-diarrheal, antacids, or medications which alter motility
- Vegetarians
- People who eat more than approximately 15 grams of fiber per day
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- General Millscollaborator
Study Sites (1)
University of Minnesota - McNeal Hall
Saint Paul, Minnesota, 55108, United States
Related Publications (1)
Timm D, Willis H, Thomas W, Sanders L, Boileau T, Slavin J. The use of a wireless motility device (SmartPill(R)) for the measurement of gastrointestinal transit time after a dietary fibre intervention. Br J Nutr. 2011 May;105(9):1337-42. doi: 10.1017/S0007114510004988. Epub 2010 Dec 8.
PMID: 21138605DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The study interventions were not randomized, which doesn't allow for period effect calculations. The SmartPill can reside in the stomach for longer than a few hours, which can skew results.
Results Point of Contact
- Title
- Dr. Joanne Slavin
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Joanne L Slavin, PhD
University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2010
First Posted
April 13, 2010
Study Start
August 1, 2009
Primary Completion
April 1, 2010
Study Completion
April 1, 2010
Last Updated
November 4, 2014
Results First Posted
October 27, 2014
Record last verified: 2014-10